Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) shares fell 3.3% during mid-day trading on Monday . The stock traded as low as $27.63 and last traded at $27.87. 183,245 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 193,516 shares. The stock had previously closed at $28.83.
Innovator IBD 50 ETF Price Performance
The stock has a market capitalization of $69.68 million, a price-to-earnings ratio of 34.39 and a beta of 1.24. The firm’s fifty day moving average is $30.29 and its 200-day moving average is $28.80.
Institutional Trading of Innovator IBD 50 ETF
Several institutional investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC increased its stake in Innovator IBD 50 ETF by 47.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 15,225 shares of the company’s stock valued at $435,000 after purchasing an additional 4,883 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Innovator IBD 50 ETF during the fourth quarter valued at $284,000. Cowa LLC increased its stake in Innovator IBD 50 ETF by 158.4% during the third quarter. Cowa LLC now owns 24,763 shares of the company’s stock valued at $666,000 after purchasing an additional 15,180 shares during the last quarter. Comprehensive Financial Planning Inc. PA bought a new stake in Innovator IBD 50 ETF during the fourth quarter valued at $437,000. Finally, Jane Street Group LLC increased its stake in Innovator IBD 50 ETF by 51.5% during the third quarter. Jane Street Group LLC now owns 49,781 shares of the company’s stock valued at $1,339,000 after purchasing an additional 16,912 shares during the last quarter.
About Innovator IBD 50 ETF
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
See Also
- Five stocks we like better than Innovator IBD 50 ETF
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- The 3 Best Fintech Stocks to Buy Now
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Invest in Small Cap Stocks
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
